Radiation dose escalation in non-small cell carcinoma of the lung

Seminars in Radiation Oncology

Volumn 14, Issue 4, 2004, Pages 287-291

  Arriagada, Rodrigo ^a   Komaki, Ritsuko ^b   Cox, James D ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN;

CANCER CHEMOTHERAPY; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE COURSE; FIELD FLOW FRACTIONATION; HUMAN; IMAGING SYSTEM; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; PRIORITY JOURNAL; RADIATION BEAM; RADIATION RESPONSE; REVIEW; STANDARD; TECHNIQUE;

EID: 8844282731     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2004.07.003     Document Type: Article

References (34)

1. C.A. Perez, K. Stanley, P. Rubin A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-small cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group Cancer 45 1980 2744 2753
2. R. Arriagada, T. Le Chevalier, E. Quoix ASTRO plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients Int J Radiat Oncol Biol Phys 20 1991 1183 1190
3. R. Arriagada, T. Le Chevalier, C. Rekacewicz Cisplatin-based chemotherapy (CT) in patients with locally advanced non-small cell lung cancer (NSCLC) late analysis of a French randomized trial Proc ASCO 16 1997 446a
4. M.I. Saunders, S. Dische, S. Barret Continuous hyperfractionated accelerated radiotherapy versus conventional radiotherapy in small-cell lung cancer a randomized multicentre trial Lancet 350 1997 161 165
5. C. Schaake-Koning, W. van den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer N Engl J Med 326 1992 524 530
6. Non-Small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer a meta-analysis using updated individual patient data from 52 randomised trials BMJ 311 1995 899 909
7. H.D. Thames, L.J. Peters, H.R. Withers Accelerated fractionation versus hyperfractionation rationales for several treatments per day Int J Radiat Oncol Biol Phys 9 1983 127 138
8. J.D. Cox Large dose fractionation (hypofractionation) Cancer 55 1985 2105 2111
9. M. Diener-West, T.F. Pajak, M. Bauer Randomized dose searching phase ILE/II trials of fractionation in radiation therapy for cancer J Natl Cancer Inst 83 1991 1065 1071
10. W.T. Sause, C. Scott, S. Taylor Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588 Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer J Natl Cancer Inst 87 1995 198 205
11. R. Komaki, C. Scott, D. Ettinger Randomized study of chemotherapy/ radiation therapy combinations for favorable patients with locally advanced inoperablenon&3x2013;small cell lung cancer Radiation Therapy Oncology Group (RTOG) 9204 Int J Radiat Oncol Biol Phys 38 1997 149 155
12. J.S. Lee, C.B. Scott, R. Komaki Impact of institutional experience on survival outcome of patients undergoing combined chemoradiation therapy for inoperable non-small-cell lung cancer Int J Radiat Oncol Biol Phys 52 2003 362 370
13. M.I. Saunders The implications of the CHART trial for the treatment of non-small cell lung cancer Lung Cancer 29 suppl 2 2000 177 178
14. R. Arriagada, L.E. Rutqvist, A. Mattsson Adequate locoregional treatment for early breast cancer may prevent secondary dissemination J Clin Oncol 13 1995 2869 2878
15. X. Qiao, O. Tullgren, L. Ingmar The role of radiotherapy in treatment of stage I non-small cell lung cancer Lung Cancer 41 2003 1 11
16. D.E. Dosoretz, M.J. Katin, P.H. Blitzer Radiation therapy in the management of medically inoperable carcinoma of the lung results and implications for future treatment strategies Int J Radiat Oncol Biol Phys 24 1992 3 9
17. J.D. Cox, F. Gingerelli, N.W. Ream Total pulmonary irradiation for metastases from testicular carcinoma Radiology 105 1972 163 167
18. M.V. Graham, J.A. Purdy, B. Emami Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer Int J Radiat Oncol Biol Phys 33 1995 993 991000
19. J.D. Bradley, M.V. Graham, K.W. Winter Acute and late toxicity results of RTOG 9311 a dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer Int J Radiat Oncol Biol Phys 57 2003 S137 S138
20. Cancer Therapy Evaluation Program Common Toxicity Criteria, Version 2.0. DCTD, NCI, NIH, DHHS 1998
21. B. Emami Optimization of volume in radiotherapy of non-small cell lung cancer small volume F. Mornex P. Van Houtte Treatment Optimization for Lung Cancer from Classical to Innovative Procedures 1998 Elsevier Publication Paris 59 65
22. J.S. Belderbos, K. De Jaeger, W.D. Heemsbergen First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy Radiother Oncol 66 2003 119 126
23. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer systematic review and meta-analysis of individual patient data from nine randomized controlled trials Lancet 352 1998 257 263
24. J. Lof, B.K. Lind, A. Brahme An adaptive control algorithm for optimization of intensity modulated radiotherapy considering uncertainties in beam profiles, patient set-up and internal organ motion Phys Med 43 1998 1605 1628
25. H.H. Liu, X. Wang, L. Dong, Q. Wu, Z. Liao, C.W. Stevens, T.M. Guerrero, R. Komaki, J.D. Cox, R. Mohan Feasibility of sparing the lung and other thoracic structures with intensity-modulated radiation therapy (IMRT) for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 58 2004 1268 1279
26. M.F. Moyers, D.W. Miller, D.A. Bush Methodologies and tools for proton beam design for lung tumors Int J Radiat Oncol Biol Phys 49 2001 1429 1438
27. Y. Shioyama, K. Tokuuye, T. Okumura Clinical evaluation of proton radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 56 2003 7 13
28. A. Auperin, C. Le Pechoux Meta-analysis of randomized trials evaluating cisplatin or carboplatin-based concomitant chemoradiation versus radiotherapy alone in locally advanced non-small cell lung cancer Lung Cancer Vol 41 2003 S69 10th World Conference on Lung Cancer. Vancouver, Canada
29. M.I. Saunders, A. Rojas, B.E. Lyn Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small cell lung cancer Br J Cancer 78 1998 1323 1328
30. R. Arriagada, S. Kleinman, L. Orlandi Induction chemotherapy followed by concurrent cisplatin and accelerated radiotherapy in locally advanced non-small cell lung cancer. (Poster) Radiother Oncol 64 2002 S262
31. H.D. Thames, S.M. Bentzen, I. Turesson Time-dose factors in radiotherapy a review of the human data Radiother Oncol 19 1990 219 235
32. J.D. Cox, N. Azarnia, R.W. Byhardt A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with > 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung cancer. Report of RTOG 83-11 J Clin Oncol 8 1990 1543 1555
33. E. Hall, C.S. Wuu Radiation-induced second cancers the impact of 3D-CRT and IMRT Int J Radiat Oncol Biol Phys 56 2003 83 88
34. A. Spira, D. Ettinger Multidisciplinary management of lung cancer N Engl J Med 350 2004 379 392